5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.60%
Negative revenue growth while HUH1V.HE stands at 4.22%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-4.22%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-5.65%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-5.65%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-12.70%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-12.50%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-12.50%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.22%
Share reduction while HUH1V.HE is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.22%
Reduced diluted shares while HUH1V.HE is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-43.60%
Negative OCF growth while HUH1V.HE is at 151.20%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-107.83%
Negative FCF growth while HUH1V.HE is at 1010.53%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-33.25%
Negative 10Y revenue/share CAGR while HUH1V.HE stands at 21.60%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-4.04%
Negative 5Y CAGR while HUH1V.HE stands at 41.20%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-7.42%
Negative 3Y CAGR while HUH1V.HE stands at 17.04%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-34.52%
Negative 10Y OCF/share CAGR while HUH1V.HE stands at 68.61%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-7.51%
Negative 5Y OCF/share CAGR while HUH1V.HE is at 87.53%. Joel Greenblatt would question the firm’s operational model or cost structure.
-56.90%
Negative 3Y OCF/share CAGR while HUH1V.HE stands at 0.90%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
165.20%
Below 50% of HUH1V.HE's 17585.12%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
62.06%
5Y net income/share CAGR above 1.5x HUH1V.HE's 20.49%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
76.98%
Positive short-term CAGR while HUH1V.HE is negative. John Neff would see a clear advantage in near-term profit trajectory.
27.54%
Below 50% of HUH1V.HE's 62.87%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
56.33%
5Y equity/share CAGR is in line with HUH1V.HE's 54.65%. Walter Schloss would see parallel mid-term profitability and retention policies.
20.12%
3Y equity/share CAGR similar to HUH1V.HE's 21.35%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-7.06%
Firm’s AR is declining while HUH1V.HE shows 0.12%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
9.98%
We show growth while HUH1V.HE is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
2.52%
Asset growth above 1.5x HUH1V.HE's 1.49%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
4.16%
BV/share growth above 1.5x HUH1V.HE's 2.50%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-5.35%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
1.04%
SG&A declining or stable vs. HUH1V.HE's 24.04%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.